KCNT2
Basic information
Region (hg38): 1:196225779-196609225
Links
Phenotypes
GenCC
Source:
- developmental and epileptic encephalopathy, 57 (Strong), mode of inheritance: AD
- developmental and epileptic encephalopathy, 57 (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Epileptic encephalopathy, early infantile, 57 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision making, and avoidance of unnecessary testing | Neurologic | 29069600 |
ClinVar
This is a list of variants' phenotypes submitted to
- Developmental and epileptic encephalopathy, 57 (3 variants)
- KCNT2-related disorder (1 variants)
- Seizure (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KCNT2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 14 | ||||
missense | 83 | 10 | 99 | |||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 2 | 3 | 1 | 6 | ||
non coding | 6 | |||||
Total | 3 | 9 | 94 | 22 | 4 |
Variants in KCNT2
This is a list of pathogenic ClinVar variants found in the KCNT2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-196228225-C-T | KCNT2-related disorder | Likely benign (Feb 18, 2019) | ||
1-196228244-G-A | Inborn genetic diseases | Uncertain significance (Aug 20, 2024) | ||
1-196228299-T-G | Likely benign (Oct 01, 2023) | |||
1-196228312-A-C | Inborn genetic diseases | Uncertain significance (Sep 22, 2023) | ||
1-196228316-G-A | Inborn genetic diseases | Uncertain significance (Mar 16, 2021) | ||
1-196228333-T-C | Uncertain significance (Oct 09, 2023) | |||
1-196235993-C-T | Developmental and epileptic encephalopathy, 57 | Uncertain significance (Jun 11, 2020) | ||
1-196236010-G-A | Inborn genetic diseases | Uncertain significance (May 05, 2023) | ||
1-196236032-G-A | KCNT2-related disorder | Likely benign (Nov 16, 2019) | ||
1-196258215-C-T | Uncertain significance (Feb 23, 2023) | |||
1-196258255-T-G | Inborn genetic diseases | Uncertain significance (Apr 07, 2022) | ||
1-196258268-C-T | Nizon-Isidor syndrome | Uncertain significance (Dec 22, 2022) | ||
1-196258280-T-C | Uncertain significance (Nov 29, 2023) | |||
1-196258286-C-A | Neurodevelopmental delay;Seizure | Likely benign (-) | ||
1-196258346-C-T | KCNT2-related disorder | Uncertain significance (Apr 16, 2024) | ||
1-196258350-G-A | Developmental and epileptic encephalopathy, 57 | Likely pathogenic (Feb 23, 2023) | ||
1-196258374-G-A | Inborn genetic diseases | Uncertain significance (Jul 30, 2024) | ||
1-196258379-A-G | Inborn genetic diseases | Uncertain significance (Sep 20, 2023) | ||
1-196258385-T-G | Uncertain significance (Nov 30, 2022) | |||
1-196258391-G-A | Uncertain significance (Sep 01, 2023) | |||
1-196258396-A-G | Developmental and epileptic encephalopathy, 57 | Benign (Aug 19, 2021) | ||
1-196258400-C-T | Inborn genetic diseases | Uncertain significance (Dec 27, 2023) | ||
1-196258445-T-C | Inborn genetic diseases | Likely benign (Jan 23, 2024) | ||
1-196258452-C-T | not specified | Uncertain significance (May 04, 2022) | ||
1-196258455-T-C | Inborn genetic diseases | Uncertain significance (May 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KCNT2 | protein_coding | protein_coding | ENST00000294725 | 28 | 383447 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0417 | 0.958 | 125724 | 0 | 23 | 125747 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.56 | 340 | 582 | 0.585 | 0.0000282 | 7452 |
Missense in Polyphen | 108 | 253.36 | 0.42627 | 3318 | ||
Synonymous | -1.10 | 223 | 203 | 1.10 | 0.0000101 | 2093 |
Loss of Function | 5.74 | 17 | 68.1 | 0.250 | 0.00000384 | 812 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000182 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000278 | 0.000272 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000891 | 0.0000879 |
Middle Eastern | 0.000278 | 0.000272 |
South Asian | 0.0000658 | 0.0000653 |
Other | 0.000175 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Outward rectifying potassium channel. Produces rapidly activating outward rectifier K(+) currents. Activated by high intracellular sodium and chloride levels (PubMed:14684870, PubMed:16687497, PubMed:29069600). Channel activity is inhibited by ATP and by inhalation anesthetics, such as isoflurane (PubMed:16687497) (By similarity). Inhibited upon stimulation of G-protein coupled receptors, such as CHRM1 and GRM1 (PubMed:16687497). {ECO:0000250|UniProtKB:Q6UVM4, ECO:0000269|PubMed:14684870, ECO:0000269|PubMed:16687497, ECO:0000269|PubMed:29069600}.;
- Disease
- DISEASE: Epileptic encephalopathy, early infantile, 57 (EIEE57) [MIM:617771]: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE57 is an autosomal dominant condition. {ECO:0000269|PubMed:29069600}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- loftool
- rvis_EVS
- -1.29
- rvis_percentile_EVS
- 5.08
Haploinsufficiency Scores
- pHI
- 0.568
- hipred
- Y
- hipred_score
- 0.725
- ghis
- 0.560
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.450
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kcnt2
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype;
Gene ontology
- Biological process
- regulation of membrane potential;potassium ion export across plasma membrane
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- intracellular sodium activated potassium channel activity;ATP binding;outward rectifier potassium channel activity;chloride-activated potassium channel activity